Explore Rankings
Journal profile · Biochemistry, Genetics and Molecular Biology

Advances in Redox Research

Elsevier BV · The Netherlands · ISSN 2667-1379

ITS Journal Score61.2
Global rank#12,188
Rank in Biochemistry, Genetics and Molecular Biology#687 of 1,066
h-index19
Open access 2021–2025100%

Overview

Advances in Redox Research, published by Elsevier BV (The Netherlands), published 133 papers in 2021–2025, and its papers received 1,331 citations in those years. Its h-index is 19 and its two-year mean citedness is 3.76. On the ITS Journal Score it ranks #12,188 of 62,158 ranked journals and #687 of 1,066 in Biochemistry, Genetics and Molecular Biology.

Key figures

Papers 2021–2025133
Citations 2021–20251,331
Citations per paper10.0
h-index19
i10-index35
2-year mean citedness3.76
Open-access share100%
Change in papers, 2020→2025300%+
Article fee (APC)US$2,130

Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.

Papers and citations by year

YearPapersCitations receivedOpen-access papers
2020000
20212323723
20222847328
20233027130
20242425324
2025289728

What it publishes

The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.

Similar journals

Ranked journals that publish on the same topics.

JournalFieldScorePapers 2021–2025Open access
MitochondrionBiochemistry, Genetics and Molecular Biology79.448137%
Redox BiologyBiochemistry, Genetics and Molecular Biology91.42,107100%
Bioenergetics CommunicationsBiochemistry, Genetics and Molecular Biology22.6108100%
Biochimica et Biophysica Acta (BBA) - BioenergeticsBiochemistry, Genetics and Molecular Biology70.799838%
Free Radical Biology and MedicineBiochemistry, Genetics and Molecular Biology84.95,41522%
Oxidative Medicine and Cellular LongevityMedicine72.72,816100%
Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseaseBiochemistry, Genetics and Molecular Biology84.21,73186%
Antioxidants and Redox SignalingMedicine83.458740%

Identity and sources

  • ISSN-L: 2667-1379
  • Print ISSN: 2667-1379
  • Publisher: Elsevier BV
  • Listed in DOAJ: Yes (checked against DOAJ)
  • Crossref: Not yet checked
  • OpenAlex: S4210180340
  • Journal website: www.journals.elsevier.com

Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.

Questions

What is the ITS Journal Score of Advances in Redox Research?

It is 61.2 out of 100, which places it #12,188 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.

What is the impact factor of Advances in Redox Research?

This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 3.76.

Is Advances in Redox Research open access?

100% of its papers from 2021–2025 are recorded as open access, and it is listed in DOAJ.

Does Advances in Redox Research charge a publication fee?

DOAJ records an article processing charge of US$2,130. Check the journal's website for the current fee and any waivers.

Transparent methodology

How the ITS Journal Score works

One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.

A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.

What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.